Position in DXCM
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$12,545,015
+$1,074,344 QoQ
Shares Held
186,266
+2.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#9
of 136 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026ISTHMUS PARTNERS, LLC holds $28,738,925 across 7 Medical Devices names. DXCM ranks #1 (43.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DXCM |
Dexcom Inc
This page
|
186,266 | $12,545,015 | |
| 2 | HAE |
Haemonetics Corp
|
65,951 | $4,946,325 | |
| 3 | BFLY |
Butterfly Network, Inc.
|
564,222 | $4,750,749 | |
| 4 | UFPT |
Ufp Technologies Inc
|
12,448 | $3,300,338 | |
| 5 | IRMD |
Iradimed Corp
|
25,586 | $2,444,998 | |
| 6 | HYPR |
Hyperfine, Inc.
|
313,350 | $423,022 | |
| 7 | ABT |
Abbott Laboratories
|
3,620 | $328,478 |
All Filings in DXCM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,545,015 | 186,266 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $11,470,671 | 182,654 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $11,711,185 | 176,453 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $11,290,319 | 167,786 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $14,611,211 | 167,387 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||